Skip to content

Effect and mechanism of hyperlipidemia on myocardial injury after non-cardiac surgery

Effect and mechanism of hyperlipidemia on myocardial injury after non-cardiac surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086771
Enrollment
Unknown
Registered
2024-07-10
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative myocardial injury

Interventions

hyperlipidemia group:Observational study , no intervention
normolipidemia group:Observational study , no intervention

Sponsors

The First People's Hospital of Yibin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Age =45 years (patient more than 45 years is at high risk of developing MINS); (2) Patients with American Society of Anaesthesiologists (ASA) physical condition class I-IV. (3) Patients type: ? Patients with lung cancer (inactive stage) who are scheduled to undergo elective radical tumour surgery. ?Patients with gastrointestinal tumours (inactive) who are scheduled to undergo elective radical tumour surgery. (4) Patients who have signed a consent form to participate in this project.

Exclusion criteria

Exclusion criteria: (1) Patients with increased preoperative troponin I (cTnI); (2) Patients with severe hepatic or renal dysfunction (liver function of Child-Pugh class C or undergoing renal replacement therapy); (3) Patients with preoperative infections: white blood cell count >10×109/L or body temperature >38.3°C; (4) Patients who did not have cTnI measurements preoperatively and did not have cTnI measurements on any of the first three postoperative days; (5) Those with elevated non-ischemic troponin (e.g., suffering from pulmonary embolism, sepsis, cardioversion, congestive heart failure, aortic valve disease, myocarditis, atrial fibrillation); (6) Patients who have not undergone preoperative lipid profile testing; (7) Those with intraoperative haemorrhage or severe drug allergy to shock;

Design outcomes

Primary

MeasureTime frame
Cardiac troponin;Serum lipid profile;Neutrophil Counts;

Secondary

MeasureTime frame
Interleukin-6;C-reactive protein;white blood cell count;Tumour necrosis factor a; Post-operative hospital stay;

Countries

China

Contacts

Public ContactYang Xue

The First People's Hospital of Yibin

953026459@qq.com+86 134 3809 6097

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026